PortfoliosLab logo
Healthcare AI Acquisition Corp. Unit (HAIAU)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG4373K1250

IPO Date

Dec 10, 2021

Highlights

Gross Profit (TTM)

-$182.27K

EBITDA (TTM)

-$583.28K

Year Range

$10.51 - $13.54

Short Ratio

1.30

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Healthcare AI Acquisition Corp. Unit (HAIAU) returned 0.09% year-to-date (YTD) and 0.36% over the past 12 months.


HAIAU

YTD

0.09%

1M

0.00%

6M

-0.98%

1Y

0.36%

3Y*

3.57%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.92%

1M

4.38%

6M

-1.84%

1Y

12.48%

3Y*

13.05%

5Y*

13.71%

10Y*

10.99%

*Annualized

Monthly Returns

The table below presents the monthly returns of HAIAU, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.09%0.00%0.00%0.00%0.00%0.00%0.09%
2024-0.09%0.00%0.00%0.00%1.65%0.00%1.27%0.27%0.09%0.27%-0.53%-1.07%1.84%
20230.97%1.64%-0.09%-0.67%0.86%0.28%1.32%2.61%4.00%-5.07%0.37%0.00%6.14%
2022-1.10%1.31%-0.60%0.85%-0.65%0.50%-0.10%0.80%0.49%-0.39%0.69%0.69%2.50%
2021-0.00%-0.00%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HAIAU is 49, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of HAIAU is 4949
Overall Rank
The Sharpe Ratio Rank of HAIAU is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of HAIAU is 4040
Sortino Ratio Rank
The Omega Ratio Rank of HAIAU is 5050
Omega Ratio Rank
The Calmar Ratio Rank of HAIAU is 5252
Calmar Ratio Rank
The Martin Ratio Rank of HAIAU is 5151
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Healthcare AI Acquisition Corp. Unit (HAIAU) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Healthcare AI Acquisition Corp. Unit Sharpe ratios as of Jun 3, 2025 (values are recalculated daily):

  • 1-Year: 0.02
  • All Time: 0.23

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Healthcare AI Acquisition Corp. Unit compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Healthcare AI Acquisition Corp. Unit doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Healthcare AI Acquisition Corp. Unit. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Healthcare AI Acquisition Corp. Unit was 15.11%, occurring on Dec 17, 2024. The portfolio has not yet recovered.

The current Healthcare AI Acquisition Corp. Unit drawdown is 10.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-15.11%Aug 8, 202492Dec 17, 2024
-5.75%Feb 28, 202368Jun 5, 202375Sep 21, 2023143
-5.07%Oct 4, 202315Oct 24, 2023195Aug 5, 2024210
-2.85%Feb 13, 20234Feb 16, 20236Feb 27, 202310
-1.49%Jan 14, 202210Jan 28, 202251Apr 12, 202261
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Healthcare AI Acquisition Corp. Unit over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Healthcare AI Acquisition Corp. Unit is priced in the market compared to other companies in the Shell Companies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HAIAU relative to other companies in the Shell Companies industry. Currently, HAIAU has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HAIAU in comparison with other companies in the Shell Companies industry. Currently, HAIAU has a P/B value of 0.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items